Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites

Details for Australian Patent Application No. 2001267553 (hide)

Owner Pharmacia Italia S.p.A.

Inventors Cozzi, Paolo; Beria, Italo; Geroni, Maria Cristina Rosa

Agent Griffith Hack

Pub. Number AU-B-2001267553

PCT Pub. Number WO01/97618

Priority 0015446 23.06.00 GB

Filing date 20 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 23 February 2006

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/475 (2006.01) - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

Event Publications

23 February 2006 Application Accepted

  Published as AU-B-2001267553

22 June 2006 Standard Patent Sealed

20 July 2006 Assignment Registered

  Pharmacia Italia S.p.A. The patent has been assigned to Nerviano Medical Sciences S.r.l.

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001267554

2001267552-Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities